Share-based Payment Arrangement, Expense in USD of Humacyte, Inc. from Q3 2020 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Humacyte, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q3 2020 to Q3 2025.
- Humacyte, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $2.51M, a 61.7% increase year-over-year.
- Humacyte, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $9.13M, a 56% increase year-over-year.
- Humacyte, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6.14M, a 10.1% decline from 2023.
- Humacyte, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.83M, a 10.4% increase from 2022.
- Humacyte, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.18M, a 39.1% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)